Clinical management of gastrointestinal stromal tumors: Before and after STI-571
University of Virginia · Oregon Health & Science University · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
637
total citations
- FWCI
- 22.52
- Percentile
- 100%
- References
- 70
Citations per year
Authors
4- RPRonald P. DeMatteoCorresponding
University of Virginia, Oregon Health & Science University, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Portland VA Medical Center
- MCMichael C. Heinrich
University of Virginia, Dana-Farber Cancer Institute, Oregon Health & Science University, Memorial Sloan Kettering Cancer Center, Portland VA Medical Center
- WEWael El‐Rifai
Portland VA Medical Center, Oregon Health & Science University, Dana-Farber Cancer Institute, University of Virginia, Memorial Sloan Kettering Cancer Center
- GDGeorge D. Demetri
University of Virginia, Oregon Health & Science University, Portland VA Medical Center, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center
Topics & keywords
Topics
Keywords
- GiST
- Stromal tumor
- Cancer research
- Tyrosine kinase
- Receptor tyrosine kinase
- Targeted therapy
- Medicine
- Gastrointestinal tract
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.